MMR Vaccination at Age 43
A 43-year-old adult who has never received or is unsure of prior MMR vaccination should receive at least one dose of MMR vaccine, and potentially two doses depending on specific risk factors.
Baseline Recommendation
Adults born in 1957 or later (which includes a 43-year-old) are not automatically considered immune to measles and mumps, unlike those born before 1957 1, 2, 1. All adults born in 1957 or later should have documentation of at least one dose of MMR vaccine unless they have laboratory evidence of immunity, a medical contraindication, or laboratory confirmation of disease 2.
When Two Doses Are Required
A second dose of MMR (minimum 28 days after the first dose) is specifically recommended if the 43-year-old falls into any of these categories 2:
- Healthcare workers (strongly recommended for all healthcare personnel regardless of birth year if lacking immunity documentation)
- Students in postsecondary educational institutions
- International travelers
- During outbreak settings or recent measles exposure
For healthcare personnel specifically, even those born before 1957 should receive 2 doses of MMR if they lack laboratory evidence of immunity 1.
Special Considerations for Women
For women of childbearing age (regardless of birth year), rubella immunity should be determined 1, 2. If there is no evidence of immunity:
- Women who are not pregnant should be vaccinated
- Pregnant women should receive MMR upon completion or termination of pregnancy and before discharge from the healthcare facility
- Women should avoid pregnancy for 1 month following vaccination 3
Acceptable Evidence of Immunity
Before vaccinating, verify if the patient has any of the following 2:
- Documentation of vaccination (1-2 doses depending on risk category)
- Laboratory evidence of immunity to each disease
- Laboratory confirmation of disease (provider diagnosis alone is NOT acceptable for rubella)
Safety Profile
The vaccine is safe in adults. Recent prospective data from 785 adults (median age 49.2 years) showed that 25.2% reported any adverse events, with 11.6% local and 18.6% systemic reactions—none were severe 4. Adverse events were more common in females (30.1% vs 19.4% in males) but remained mild 4.
Practical Algorithm
- Verify birth year: Born 1957 or later? → Proceed to step 2
- Check documentation: Any proof of MMR vaccination or laboratory immunity?
- If YES and not high-risk → May not need vaccination
- If NO or uncertain → Proceed to step 3
- Assess risk category:
- Healthcare worker, student, or international traveler? → Give 2 doses (28 days apart)
- None of the above? → Give 1 dose minimum
- For women: Confirm not pregnant; counsel on 1-month pregnancy avoidance post-vaccination
Common Pitfall
Do not rely on patient-reported history of disease as evidence of immunity, especially for rubella—laboratory confirmation is required 2, 5. Provider-diagnosed disease is no longer considered acceptable evidence of immunity for measles and mumps either 5.
The vaccine is FDA-approved for individuals 12 months of age and older 3, making it appropriate for this 43-year-old patient. Given the resurgence of measles outbreaks even in previously eliminated regions 6, 5, vaccination is particularly important for adults lacking documented immunity.